Breaking News Instant updates and real-time market news.

LPCN

Lipocine

$3.80

-0.35 (-8.43%)

08:03
10/17/16
10/17
08:03
10/17/16
08:03

Lipocine completes post action meeting with FDA for LPCN 1021 NDA

Lipocine announced the completion of a Post Action meeting with the FDA regarding its New Drug Application, or NDA, for LPCN 1021, an oral testosterone product candidate for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone, also known as hypogonadism. The purpose of the meeting was to review the Complete Response Letter, or CRL, and to determine actions needed to achieve approval of LPCN 1021. The CRL, issued June 28, 2016, identified deficiencies related to the dosing algorithm for the label. In response to the CRL, Lipocine proposed a dosing regimen based on analyses of existing data. The FDA noted that while Lipocine's proposed dosing regimen might be acceptable, validation in a clinical trial would be needed prior to resubmission. As a result, Lipocine has submitted the new dosing validation clinical study protocol to the FDA and the FDA has agreed to review the protocol through a Special Protocol Assessment. An SPA is an advanced declaration from the FDA that a planned trial's design, clinical endpoints, and statistical analyses could potentially result in data acceptable for FDA review towards approval for the proposed indication.

LPCN Lipocine
$3.80

-0.35 (-8.43%)

06/30/16
ROTH
06/30/16
NO CHANGE
Target $30
ROTH
Buy
Lipocine price target lowered to $30 from $40 at Roth Capital
Roth Capital analyst Michael Higgins lowered his price target for Lipocine to $30 from $40 after the FDA issued a Complete Response Letter on Lipocine's oral testosterone product, LPCN 1021, citing "deficiencies related to the dosing algorithm." Roth Capital has a Buy rating on the shares.
10/07/16
HCWC
10/07/16
INITIATION
Target $25
HCWC
Buy
Lipocine initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Corey Davis started Lipocine with a Buy rating and $25 price target.
10/11/16
ADAM
10/11/16
NO CHANGE
Target $15
ADAM
Buy
Lipocine price target raised to $15 from $6 at Canaccord
Canaccord analyst John Newman raised his price target on Lipocine to $15 from $6 as he believes its oral testosterone product has better safety and convenience versus currently marketed gels and injectables. The analyst sees rapid market share gains and a 20% market share by 2024. Newman reiterated his Buy rating on Lipocine shares.

TODAY'S FREE FLY STORIES

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

, MTSI

MACOM

$58.26

1.76 (3.12%)

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Recommendations
Applied Optoelectronics, MACOM, Fabrinet, Amazon.com analyst commentary  »

Needham says Applied…

AAOI

Applied Optoelectronics

$65.87

2.29 (3.60%)

MTSI

MACOM

$58.26

1.76 (3.12%)

FN

Fabrinet

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

AAPL

Apple

$146.28

0.65 (0.45%)

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Technical Analysis
Technical View: Apple rises, levels to watch »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

LOW

Lowe's

, VRX

Valeant

09:40
06/26/17
06/26
09:40
06/26/17
09:40
Options
Unusually active option classes on open June 26th »

Unusual total active…

LOW

Lowe's

VRX

Valeant

CSCO

Cisco

$32.09

0.24 (0.75%)

BIDU

Baidu

$178.14

-1.19 (-0.66%)

P

Pandora

NKE

Nike

TWTR

Twitter

COST

Costco

$157.13

-2.66 (-1.66%)

GLD

SPDR Gold Trust

AAPL

Apple

$146.28

0.65 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 19

    Jul

  • 16

    Aug

  • 23

    Aug

  • 24

    Aug

09:40
06/26/17
06/26
09:40
06/26/17
09:40
General news
Vehicle Inventories Pose Risk For Auto Retooling »

Vehicle Inventories Pose…

ARNC

Arconic

09:38
06/26/17
06/26
09:38
06/26/17
09:38
Technical Analysis
Technical View: Arconic trades sharply lower »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCAP

Triangle Capital

09:37
06/26/17
06/26
09:37
06/26/17
09:37
Upgrade
Triangle Capital rating change  »

Triangle Capital upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FE

FirstEnergy

09:35
06/26/17
06/26
09:35
06/26/17
09:35
Upgrade
FirstEnergy rating change  »

FirstEnergy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

09:35
06/26/17
06/26
09:35
06/26/17
09:35
Recommendations
Fabrinet, Amazon.com, Tesla analyst commentary  »

Fabrinet price target…

FN

Fabrinet

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

TSLA

Tesla

$383.45

0.84 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 13

    Jul

  • 29

    Aug

  • 02

    Oct

SGEN

Seattle Genetics

$61.74

-1.51 (-2.39%)

09:31
06/26/17
06/26
09:31
06/26/17
09:31
Recommendations
Seattle Genetics analyst commentary  »

Seattle Genetics data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

MDXG

MiMedx

$15.71

0.14 (0.90%)

09:30
06/26/17
06/26
09:30
06/26/17
09:30
Recommendations
MiMedx analyst commentary  »

MiMedx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

, COST

Costco

$157.13

-2.66 (-1.66%)

09:28
06/26/17
06/26
09:28
06/26/17
09:28
Conference/Events
Cowen internet and retail analysts hold an analyst/industry conference call »

Internet & New Media…

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

COST

Costco

$157.13

-2.66 (-1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 23

    Aug

CGIX

Cancer Genetics

$3.85

0.05 (1.32%)

09:27
06/26/17
06/26
09:27
06/26/17
09:27
Initiation
Cancer Genetics initiated  »

Cancer Genetics initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$1.14

-0.16 (-12.31%)

09:27
06/26/17
06/26
09:27
06/26/17
09:27
Hot Stocks
Trovagene reports receipt of notice of event of default from lender »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBTX

Independent Bank

$54.85

-1.1 (-1.97%)

09:22
06/26/17
06/26
09:22
06/26/17
09:22
Upgrade
Independent Bank rating change  »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

CSCO

Cisco

$32.09

0.24 (0.75%)

09:22
06/26/17
06/26
09:22
06/26/17
09:22
Recommendations
Cisco analyst commentary  »

Cisco intent-based…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 12

    Jul

  • 12

    Jul

  • 13

    Jul

  • 16

    Aug

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
06/26/17
06/26
09:18
06/26/17
09:18
Options
Overnight activity included 119 trades in SPX and 25 trades in VIX »

119 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNC

Synacor

, T

AT&T

09:16
06/26/17
06/26
09:16
06/26/17
09:16
Recommendations
Synacor, AT&T analyst commentary  »

AT&T portal ramping…

SYNC

Synacor

T

AT&T

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$71.21

0.95 (1.35%)

09:11
06/26/17
06/26
09:11
06/26/17
09:11
Periodicals
LinkedIn's president of China set to depart, TechCrunch says »

Derek Shen, president of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 20

    Jul

HD

Home Depot

09:11
06/26/17
06/26
09:11
06/26/17
09:11
Hot Stocks
Breaking Hot Stocks news story on Home Depot »

Home Depot up 49c to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNVC

NanoViricides

09:11
06/26/17
06/26
09:11
06/26/17
09:11
Hot Stocks
NanoViricides to present nanoviricide poster at ASV »

NanoViricides is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MACE

Mace Security

09:09
06/26/17
06/26
09:09
06/26/17
09:09
Hot Stocks
Mace Security announces expansion of e-commerce business distribution »

Mace Security…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVA

Sinovac Biotech

$5.70

-0.02 (-0.35%)

09:07
06/26/17
06/26
09:07
06/26/17
09:07
Hot Stocks
Sinovac Biotech enters definitive agreement for going-private transaction »

Sinovac Biotech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LWAY

Lifeway Foods

$9.36

-0.06 (-0.64%)

09:07
06/26/17
06/26
09:07
06/26/17
09:07
Hot Stocks
Lifeway Foods commences self-tender offer for up to $6M of common stock »

Lifeway Foods has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$84.83

0.4 (0.47%)

, HON

Honeywell

$133.99

-0.08 (-0.06%)

09:06
06/26/17
06/26
09:06
06/26/17
09:06
Periodicals
Loeb has 'more urgency' in Nestle campaign than with Honeywell, CNBC says »

Dan Loeb has already held…

NSRGY

Nestle

$84.83

0.4 (0.47%)

HON

Honeywell

$133.99

-0.08 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

  • 26

    Jul

HPQ

HP Inc.

$17.80

0.09 (0.51%)

09:06
06/26/17
06/26
09:06
06/26/17
09:06
Recommendations
HP Inc. analyst commentary  »

HP Inc. shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.